US Edition
News about Novo Nordisk
Stay current with all the latest and breaking news about Novo Nordisk, compare headlines and perspectives between news sources on stories happening today. In total, 170 stories have been published about Novo Nordisk which Ground News has aggregated in the past 3 months.
Covered Most By
Local News Publishers
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Novo Nordisk News
Novo Nordisk · DenmarkNovo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main goal in late-stage trials testing whether the medicine can slow cognitive decline in Alzheimer's patients, sending its share price down 10%.See the Story
Novo Nordisk says Alzheimer's drug trial fails, hammering shares
62% Center coverage: 62 sources
DiabetesNovo Nordisk A/S (NYSE:NVO) on Tuesday released headline results from a phase 2 trial with amycretin for type 2 diabetes. The update marks the first evaluation of amycretin in people with type 2 diabetes. Novo Nordisk is planning to initiate a phase 3 development program with amycretin for adults with type 2 diabetes in 2026. In June, the company said it planned to initiate a phase 3 development for amycretin for adults with overweight or obesit…See the Story
Novo Nordisk Signals 2026 Push After Amycretin Posts Major Phase 2 Gains In Type 2 Diabetes Patients - Novo Nordisk (NYSE:NVO)
75% Center coverage: 4 sources
